<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03302481</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0055</org_study_id>
    <nct_id>NCT03302481</nct_id>
  </id_info>
  <brief_title>Mitochondrial Metabolism and Hepatic Complications of Obesity</brief_title>
  <acronym>DMSO</acronym>
  <official_title>Prospective Physiopathology Study of the Links Between Mitochondrial Dynamics and Fatty Liver Disease During Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to characterize mitochondrial metabolism in the liver of obesity surgery
      patients and to study its relationships with hepatic steatosis, inflammation, and fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to characterize mitochondrial metabolism in the liver of obesity surgery
      patients and to study its relationships with hepatic steatosis, inflammation, and fibrosis.
      The protocols involves a per-operative hepatic needle biopsy for mitochondria
      characterization and histological scoring of steatosis, inflammation, and fibrosis
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>patients with obesity surgery with a laparoscopic approach scheduled in the department of digestive surgery of the CHU de Nantes</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Association between nonalcoholic steato-hepatitis and mitochondria morphological markers</measure>
    <time_frame>Until 6 month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the biopsies will be performed under laparoscopy and taken in the lower part of the right hepatic lobe</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>liver biopsy</intervention_name>
    <description>the biopsies will be performed under laparoscopy and taken in the lower part of the right hepatic lobe</description>
    <arm_group_label>Experimental Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult men and women

          -  affiliated to a social security

          -  candidate for laparoscopic obesity surgery

        Exclusion Criteria:

          -  Excessive alcohol consumption:&gt; 20 g / day (woman),&gt; 30 g / day (male)

          -  Chronic viral hepatitis B or C

          -  Genetic hemochromatosis

          -  Taking the following drugs for at least 3 months up to 6 months before the scheduled
             date of obesity surgery: systemic corticosteroids, amiodarone, methotrexate

          -  Wilson's disease

          -  autoimmune hepatitis

          -  alpha 1-antitrypsin deficiency

          -  abetalipoproteinemia

          -  Contraindications to liver biopsy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David JACOBI, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David JACOBI, Dr</last_name>
    <phone>02.53.48.27.07</phone>
    <email>david.jacobi@univ-nantes.fr</email>
  </overall_contact>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2017</study_first_submitted>
  <study_first_submitted_qc>October 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2017</study_first_posted>
  <last_update_submitted>October 4, 2017</last_update_submitted>
  <last_update_submitted_qc>October 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity surgery</keyword>
  <keyword>liver</keyword>
  <keyword>mitochondria</keyword>
  <keyword>steatosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

